The nanopore optofluidic chip used in the new diagnostic system, with a PCR thermocycler in the background for comparison. The new system could easily fit into a researcher’s lab or clinician’s office ...
Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...
The Australian patent represents the first patent granted for the Company's new point-of-care testing platform ...
Real-time PCR (qPCR) analysis has become the method of choice for quantitating DNA in a wide variety of applications. The availability of commercial kits has made the technique easy to perform, ...
As the federal health emergency ended May 11 and COVID numbers are on the rise, here’s how you can still access tests, at-home and PCR. (Michael Bocchieri/Getty Images) It’s that time again: COVID-19 ...
LOS ANGELES--(BUSINESS WIRE)--Curative Inc., a leading health services company that recently launched a new health plan out of Texas, announces the spin-off of Sensible Diagnostics, whose aim is to ...
Respiratory syncytial virus (RSV) was detected easiest when using reverse transcription polymerase chain reaction (RT-PCR) tests in a pediatric population. Reverse transcription polymerase chain ...
If you had COVID-19 symptoms in 2020, you probably would have masked up and braved a visit to a laboratory, doctor’s office, or clinic to get a polymerase chain reaction (PCR) test. A health care ...
Hosted on MSN
Cell-free RNA blood test identifies early-stage cancers, monitors treatment resistance and detects tissue damage
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test analyzes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback